Patents by Inventor Hui-Jan Hsu

Hui-Jan Hsu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibody-drug conjugates and uses thereof
    Patent number: 11384150
    Abstract: An immunoconjugate, comprising an anti-EGFR antibody or a binding fragment thereof, and a kinase inhibitor.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: July 12, 2022
    Assignees: Development Center for Biotechnology, Tunghai University
    Inventors: Shih-Hsien Chuang, Wei-Ting Chao, Wei-Ting Sun, Hui-Jan Hsu, Wun-Huei Lin
  • ANTIBODY-DRUG CONJUGATES AND USES THEREOF
    Publication number: 20200190199
    Abstract: An immunoconjugate, comprising an anti-EGFR antibody or a binding fragment thereof, and a kinase inhibitor.
    Type: Application
    Filed: December 13, 2017
    Publication date: June 18, 2020
    Inventors: Shih-Hsien Chuang, Wei-Ting Chao, Wei-Ting Sun, Hui-Jan Hsu, Wun-Huei Lin
  • ANTI-CANCER STEMNESS DRUGS
    Publication number: 20200062738
    Abstract: A compound for inhibiting BMI-1/MCL-1 having a structure of Formula (I), wherein the various groups are as described. A pharmaceutical composition for treating cancer includes an effective amount of a compound of Formula (I).
    Type: Application
    Filed: April 30, 2018
    Publication date: February 27, 2020
    Applicants: Development Center for Biotechnology, National Yang-Ming University
    Inventors: Cheng-Wen Wu, Erh-Hsuan Jiann Lin, Chi-Ying Huang, Jia-Ming Chang, Shih-Hsien Chuang, Hui-Jan Hsu, Wei-Wei Chen